1- [ 2,5-dichloro-6- [ 1- ( 1h-imidazol-1-yl ) -ethenyl ] phenoxy ] -3- [ ( 1-methylethyl ) amino ] -2-propanol hydrochloride ( 48 ) ( 711389-s ) was selected as a candidate for clinical evaluation in man , since its antiarrhythmic effects were superior to those of quinidine , disopyramide , or propranolol .
C0003195
antiarrhythmic
C0012702
disopyramide